Erschienen in:
18.02.2020 | HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)
Obesity and Weight Gain in Persons with HIV
verfasst von:
Samuel S. Bailin, Curtis L. Gabriel, Celestine N. Wanjalla, John R. Koethe
Erschienen in:
Current HIV/AIDS Reports
|
Ausgabe 2/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
The proportion of overweight and obese persons with HIV (PWH) has increased since the introduction of antiretroviral therapy (ART). We aim to summarize recent literature on risks of weight gain, discuss adipose tissue changes in HIV and obesity, and synthesize current understanding of how excess adiposity and HIV contribute to metabolic complications.
Recent Findings
Recent studies have implicated contemporary ART regimens, including use of integrase strand transfer inhibitors and tenofovir alafenamide, as a contributor to weight gain, though the mechanisms are unclear. Metabolic dysregulation is linked to ectopic fat and alterations in adipose immune cell populations that accompany HIV and obesity. These factors contribute to an increasing burden of metabolic diseases in the aging HIV population.
Summary
Obesity compounds an increasing burden of metabolic disease among PWH, and understanding the role of fat partitioning and HIV- and ART-related adipose tissue dysfunction may guide prevention and treatment strategies.